👏 Congratulations to our 15 Research Scholar Awardees!
The awardees are rising researchers advancing earlier detection, more personalized therapies and improved outcomes across urologic disease. This year’s awardees represent a diverse range of research areas—from cancer biology and artificial intelligence to pediatric care and infection prevention.
🔗 Click to learn more about the program and the awardees: bit.ly/4r5ABpA
Patients with homozygous BRCA loss had the most durable outcomes on single-agent PARPi. However, difficult to detect these extreme responders on liquid biopsy without very high ctDNA fraction (>20%).
🚨Hot off the press...📰
Check out the newest publication from the Prostate Team!
The article hightlights what MUSIC has learned about recovery of social continence and sexual function following radical prostatectomy in men with high-risk prostate cancer.
Check out the fulltext article here:
🔗musicurology.com/wp-content/…#PCA#ProstateCancer#urology@TrinerDaniel
Unbelievably proud of these two for matching at their top choice 🥇for SUO @UroOnc Fellowship
These guys are awesome clinicians, researchers, coresidents, and have become two of my best friends.
CONGRATS!
@TrinerDaniel 🌲@StanfordUrology@ApoorvDhir 🐏 @UNCurology
Just out in @JAMA_current: Long-term outcomes of prostate cancer AS in PASS. Since 2008:
➡️2,155 patients with median 7.2 year f/u.
➡️21 patients have developed metastatic disease
➡️3 prostate cancer-related deaths
jamanetwork.com/journals/jam…
Track each patient 👇
Congratulations to our newest member of the Urologic Oncology family! We are thrilled to welcome @alexzhuDO to @UroOnc where we will continue expanding our knowledge and shaping the future of urologic oncology @UWMedicine 👏👏